PT  - JOURNAL ARTICLE
AU  - Pieruzzini Rosalinda
AU  - Ayala-Grosso Carlos
AU  - Navas José de Jesús
AU  - Rodríguez Wilneg Carolina
AU  - Parra Nathalia
AU  - Luque Emily
AU  - Sánchez Gago Aida
AU  - González Scarleth
AU  - Hagobian Alexandra
AU  - Grullón Angeline
AU  - Díaz Karen
AU  - Morales Mariano
AU  - De Jesús Melanie
AU  - Peña Sonia
AU  - Rodríguez Luis
AU  - Peña Luis Lenin
AU  - Asaro Ana
AU  - Magris Magda
TI  - PREDICTIVE VALUE OF SMELL AND TASTE TEST VS PCR-RT SARS-COV-2 AND RAPID DIAGNOSTIC TESTS IN THE DIAGNOSIS OF INFECTION BY COVID-19. A PROSPECTIVE MULTI-CENTRIC STUDY
AID  - 10.1101/2020.08.31.20185298
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.31.20185298
4099  - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185298.short
4100  - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185298.full
AB  - There is a relationship between smell and taste disturbances and coronavirus infection. These symptoms have been considered the best predictor of coronavirus infection, for this reason, it was decided to evaluate the predictive value of the smell and taste test and its association with the results of SARS-CoV-2 PCR-RT and rapid diagnostic tests. in the diagnosis of pathology. Methodology: 248 patients divided into 3 groups: asymptomatic, symptomatic without chemosensory disorders, and chemosensory disorders alone. All of them underwent SARS-CoV-2 PCR-RT, a rapid diagnostic test and a test of Venezuelan smell and basic taste at the beginning. Weekly follow-up with smell and taste test and SARS-CoV-2 PCR-RT until recovery. Results: 20.56% of patients had smell and taste disorders to a variable degree and were positive by SARS-CoV-PCR-RT. 2.15.3% of patients with chemosensory disorders were negative for COVID-19. The positive predictive value of the smell and taste test was 57.3; Sensitivity 41.13% and specificity 69.35%. There were no statistically significant differences by age, sex and chemosensory disorders. The predominant chemosensory disorder was the combination of mild hyposmia and hypogeusia and appeared in the company of other symptoms. Recovery occurred in an average of 8.5 days, asynchronously with the SARS-CoV-2 RT-PCR negativization, which occurred up to more than 15 days after the senses recovered. Maximum time of negativization of the RT-PCR of 34 days. Conclusion: chemosensory disorders are a symptom and / or sign of coronavirus disease but cannot be considered as predictors of said disease in this population studied. The gold standard remains the SARS-CoV-2 PCR-RT test. Rapid diagnostic tests should be used for follow-up. Recommendations: it is necessary to expand the sample, include routine psychophysical smell and taste tests to screen cases and take race and virus mutations into consideration to explain behavior in certain populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSelf-financed by the authors and the Ministry of People's Power for HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Bioethics Commission of the Hospital Militar Universitario Dr. Carlos ArveloAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data can be used https://doi.org/10.1101/2020.04.29.069054 https://www.medrxiv.org/content/10.1101/2020.08.25.20182063v1